Tofacitinib versus Vedolizumab Among Bio-naïve Patients with Ulcerative Colitis: A Real-World Propensity-Weighted Comparison
AbstractBACKGROUND AND AIMS. Over the last decade, treatment options for moderate-to-severe ulcerative colitis (UC) have expanded. However, comparative stu